Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2004-01-05 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-POL-SUR-TERNOISE (62130), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU TERNOIS : revenue, balance sheet and financial ratios
PHARMACIE DU TERNOIS is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-POL-SUR-TERNOISE (62130),
this company of category PME
shows in 2023 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU TERNOIS (SIREN 451483382)
Indicator
2024
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 346 757 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
43 542 €
93 698 €
144 085 €
134 435 €
84 234 €
116 085 €
83 069 €
107 273 €
109 469 €
EBITDA
N/C
N/C
130 068 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.1%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU TERNOIS generates positive net income of 44 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 109 k€ -> 44 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 542 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.036%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
87.506%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU TERNOIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2024
Debt ratio
30.292
20.502
12.989
5.96
3.441
0.039
0.007
116.421
0.036
Financial autonomy
68.976
73.631
79.313
83.731
85.004
85.057
86.688
40.297
87.506
Repayment capacity
None
None
None
None
None
None
0.001
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
5.876%
None%
None%
Sector positioning
Debt ratio
0.042024
2023
2024
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DU TERNOIS (0.04) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
87.51%2024
2023
2024
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+13 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU TERNOIS (87.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.0 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DU TERNOIS (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 160.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
160.174
Liquidity indicators evolution PHARMACIE DU TERNOIS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2024
Liquidity ratio
156.435
153.681
152.2
155.35
148.737
139.778
168.349
206.328
160.174
Interest coverage
None
None
None
None
None
None
0.0
None
None
Sector positioning
Liquidity ratio
160.172024
2023
2024
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average
In 2024, the liquidity ratio of PHARMACIE DU TERNOIS (160.17) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
0.0x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DU TERNOIS (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU TERNOIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
246 081 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
34
0
0
Customer payment term (days)
0
0
0
0
0
0
5
0
0
Supplier payment term (days)
0
0
0
0
0
0
42
0
0
Positioning of PHARMACIE DU TERNOIS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU TERNOIS is estimated at
607 878 €
(range 423 316€ - 909 421€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
423k€607k€909k€
607 878 €Range: 423 316€ - 909 421€
NAF 5 année 2024
Valuation method used
Net Income Multiple
43 542 €
×
14.0x
=607 879 €
Range: 423 317€ - 909 421€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU TERNOIS with other companies in the same sector:
Frequently asked questions about PHARMACIE DU TERNOIS
What is the revenue of PHARMACIE DU TERNOIS ?
The revenue of PHARMACIE DU TERNOIS in 2023 is 2.3 M€.
Is PHARMACIE DU TERNOIS profitable?
Yes, PHARMACIE DU TERNOIS generated a net profit of 44 k€ in 2024.
Where is the headquarters of PHARMACIE DU TERNOIS ?
The headquarters of PHARMACIE DU TERNOIS is located in SAINT-POL-SUR-TERNOISE (62130), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE DU TERNOIS ?
The tax return of PHARMACIE DU TERNOIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU TERNOIS operate?
PHARMACIE DU TERNOIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart